Squamous Cell Carcinoma of the Bladder
Drug | Drug Name | Drug Description |
---|
Drug | Drug Name | Target | Type |
---|
Drug | Drug Name | Phase | Status | Count |
---|---|---|---|---|
DB08885 | Aflibercept | 2 | Completed | 1 |
DB11595 | Atezolizumab | 2 | Not Yet Recruiting | 1 |
DB00958 | Carboplatin | 2 | Completed | 1 |
DB00515 | Cisplatin | 2 | Terminated | 1 |
DB11714 | Durvalumab | 2 | Completed | 1 |
DB13007 | Enfortumab vedotin | 2 | Not Yet Recruiting | 1 |
DB00441 | Gemcitabine | 2 | Completed | 1 |
DB00441 | Gemcitabine | 2 | Terminated | 1 |
DB01229 | Paclitaxel | 2 | Completed | 1 |
DB09037 | Pembrolizumab | 2 | Not Yet Recruiting | 1 |
DB12893 | Sacituzumab govitecan | 2 | Not Yet Recruiting | 1 |
DB00398 | Sorafenib | 2 | Terminated | 1 |
DB00072 | Trastuzumab | 2 | Completed | 1 |
DB11771 | Tremelimumab | 2 | Completed | 1 |